UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

miR‐31/QKI‐5 axis facilitates cell cycle progression of non‐small‐cell lung cancer cells by interacting and regulating p21 and CDK4/6 expressions

Cancer medicine (Malden, MA), 2023-02, Vol.12 (4), p.4590-4604

2023

Volltextzugriff (PDF)

Evaluation of the preoperative neutrophil-to-lymphocyte ratio as a predictor of the micropapillary component of stage IA lung adenocarcinoma

Journal of international medical research, 2024-04, Vol.52 (4), p.3000605241245016-3000605241245016

2024

Volltextzugriff (PDF)

Association of lymph node involvement with the prognosis of pathological T1 invasive non-small cell lung cancer

World journal of surgical oncology, 2017-03, Vol.15 (1), p.64-64, Article 64

2017

Volltextzugriff (PDF)

Epidermal Growth Factor Receptor Mutations and Their Prognostic Value with Carcinoembryonic Antigen in Pathological T1 Lung Adenocarcinoma

Disease markers, 2018-01, Vol.2018 (2018), p.1-13

2018

Volltextzugriff (PDF)

Differentiating Preinvasive from Invasive Lung Adenocarcinoma Appearing as Part-Solid Ground-Glass Nodule Using CT Value and Solid-Part Diameter

Iranian journal of radiology, 2018-01, Vol.15 (1)

2018

Volltextzugriff (PDF)

Evaluation of dynamic change of serum miR-21 and miR-24 in pre- and post-operative lung carcinoma patients

Medical oncology (Northwood, London, England), 2012-12, Vol.29 (5), p.3190-3197

2012

Volltextzugriff (PDF)

Differential Expression of miR-125a-5p and let-7e Predicts the Progression and Prognosis of Non-Small Cell Lung Cancer

Cancer investigation, 2014-09, Vol.32 (8), p.394-401

2014

Volltextzugriff (PDF)

Prognostic value of mutant p53, Ki-67, and TTF-1 and their correlation with EGFR mutation in patients with non-small cell lung cancer

Histology and histopathology, 2019-11, Vol.34 (11), p.1269

2019

Volltextzugriff (PDF)

miRNAs expression profiling to distinguish lung squamous-cell carcinoma from adenocarcinoma subtypes

Journal of cancer research and clinical oncology, 2012-10, Vol.138 (10), p.1641-1650

2012

Volltextzugriff (PDF)

Cancer‑associated fibroblasts, matrix metalloproteinase‑9 and lymphatic vessel density are associated with progression from adenocarcinoma in situ to invasive adenocarcinoma of the lung

Oncology letters, 2020-11, Vol.20 (5), p.1-1

2020

Volltextzugriff (PDF)

A Prediction Rule for Overall Survival in Non-Small-Cell Lung Cancer Patients with a Pathological Tumor Size Less Than 30 mm

Disease markers, 2019, Vol.2019 (2019), p.1-9

2019

Volltextzugriff (PDF)

The role of mitochondrial tRNA mutations in lung cancer

International journal of clinical and experimental medicine, 2015-01, Vol.8 (8), p.13341-13346

2015

Volltextzugriff (PDF)

Tim-3 expression by peripheral natural killer cells and natural killer T cells increases in patients with lung cancer--reduction after surgical resection

Asian Pacific journal of cancer prevention : APJCP, 2014-01, Vol.15 (22), p.9945-9948

2014

Volltextzugriff (PDF)

Identification of Factors for the Preoperative Prediction of Tumour Subtype and Prognosis in Patients with T1 Lung Adenocarcinoma

Disease markers, 2016-01, Vol.2016 (2016), p.1-10

2016

Volltextzugriff (PDF)

Diagnostic Value of Serum miR-182, miR-183, miR-210, and miR-126 Levels in Patients with Early-Stage Non-Small Cell Lung Cancer

PloS one, 2016-04, Vol.11 (4), p.e0153046-e0153046

2016

Volltextzugriff (PDF)

Polydatin, a potential NOX5 agonist, synergistically enhances antitumor activity of cisplatin by stimulating oxidative stress in non‑small cell lung cancer

International journal of oncology, 2024-08, Vol.65 (2), Article 77

2024

Volltextzugriff (PDF)

Impact of minimal solid and micropapillary components on invasive lung adenocarcinoma recurrence

Annals of diagnostic pathology, 2022-08, Vol.59, p.151945-151945, Article 151945

2022

Volltextzugriff (PDF)

Tim-3 Expression by Peripheral Natural Killer Cells and Natural Killer T Cells Increases in Patients with Lung Cancer - Reduction after Surgical Resection

Asian Pacific journal of cancer prevention : APJCP, 2014, Vol.15 (22), p.9945-9948

2014

Volltextzugriff (PDF)

Enhancement pattern of thyroid carcinoma with contrast-enhanced ultrasound

Zhong hua yi xue za zhi, 2010-01, Vol.90 (1), p.42-45

2010

Volltextzugriff (PDF)

Robust Binary Neural Network Operation From 233 K to 398 K via Gate Stack and Bias Optimization of Ferroelectric FinFET Synapses

IEEE electron device letters, 2021-08, Vol.42 (8), p.1144-1147

2021

Volltextzugriff (PDF)

Rational application of EGFR-TKI adjuvant therapy in patients with completely resected stage IB-IIIA EGFR-mutant NSCLC: a systematic review and meta-analysis of 11 randomized controlled trials

BMC cancer, 2023-08, Vol.23 (1), p.719-719, Article 719

2023

Volltextzugriff (PDF)

Neoadjuvant EGFR-TKI Therapy for EGFR-Mutant NSCLC: A Systematic Review and Pooled Analysis of Five Prospective Clinical Trials

Frontiers in oncology, 2021-01, Vol.10, p.586596

2021

Volltextzugriff (PDF)

Facile Approach for Designing Icephobic Coatings Using Polymers/Silica Nanoparticle Composites via Self‐Formation of Superhydrophobic Surfaces

Advanced materials interfaces, 2024-04, Vol.11 (11), p.n/a

2024

Volltextzugriff (PDF)

Area-Selective Deposition of Ruthenium Using Homometallic Precursor Inhibitor

Chemistry of materials, 2023-07, Vol.35 (14), p.5331-5340

2023

Volltextzugriff (PDF)

Clinical option of pemetrexed-based versus paclitaxel-based first-line chemotherapeutic regimens in combination with bevacizumab for advanced non-squamous non-small-cell lung cancer and optimal maintenance therapy: evidence from a meta-analysis of randomized control trials

BMC cancer, 2021-04, Vol.21 (1), p.426-11, Article 426

2021

Volltextzugriff (PDF)

1 – 25 von 90

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(72)
Mit Volltextzugriff
(81)

Publikationsform

Artikel
(88)
Tagungsberichte
(2)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(66)
Life Sciences & Biomedicine
(51)
Humans
(36)
Oncology
(27)
Lung Cancer
(22)
Male
(21)
Female
(20)
Lung Neoplasms - Pathology
(16)
Middle Aged
(16)
Aged
(12)
Prognosis
(12)
Cancer Therapies
(11)
Medical Prognosis
(11)
Non-Small Cell Lung Cancer
(11)
Adult
(10)
Chemotherapy
(10)
Lung Neoplasms - Drug Therapy
(10)
Technology
(10)
Carcinoma, Non-Small-Cell Lung - Pathology
(9)
Care And Treatment
(9)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

中华医学杂志
(4)
Bmc Cancer
(3)
Cancer Medicine
(3)
Chinese Medical Journal
(3)
Disease Markers
(3)
Frontiers In Oncology
(3)
Lung
(3)
Plos One
(3)
Asian Pacific Journal Of Cancer Prevention : Apjcp
(2)
Chemistry Of Materials
(2)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

miR‐31/QKI‐5 axis facilitates cell cycle progression of non‐small‐cell lung cancer cells by interacting and regulating p21 and CDK4/6 expressions

Evaluation of the preoperative neutrophil-to-lymphocyte ratio as a predictor of the micropapillary component of stage IA lung adenocarcinoma

Association of lymph node involvement with the prognosis of pathological T1 invasive non-small cell lung cancer

Epidermal Growth Factor Receptor Mutations and Their Prognostic Value with Carcinoembryonic Antigen in Pathological T1 Lung Adenocarcinoma

Differentiating Preinvasive from Invasive Lung Adenocarcinoma Appearing as Part-Solid Ground-Glass Nodule Using CT Value and Solid-Part Diameter

Evaluation of dynamic change of serum miR-21 and miR-24 in pre- and post-operative lung carcinoma patients

Differential Expression of miR-125a-5p and let-7e Predicts the Progression and Prognosis of Non-Small Cell Lung Cancer

Prognostic value of mutant p53, Ki-67, and TTF-1 and their correlation with EGFR mutation in patients with non-small cell lung cancer

miRNAs expression profiling to distinguish lung squamous-cell carcinoma from adenocarcinoma subtypes

Cancer‑associated fibroblasts, matrix metalloproteinase‑9 and lymphatic vessel density are associated with progression from adenocarcinoma in situ to invasive adenocarcinoma of the lung

A Prediction Rule for Overall Survival in Non-Small-Cell Lung Cancer Patients with a Pathological Tumor Size Less Than 30 mm

The role of mitochondrial tRNA mutations in lung cancer

Tim-3 expression by peripheral natural killer cells and natural killer T cells increases in patients with lung cancer--reduction after surgical resection

Identification of Factors for the Preoperative Prediction of Tumour Subtype and Prognosis in Patients with T1 Lung Adenocarcinoma

Diagnostic Value of Serum miR-182, miR-183, miR-210, and miR-126 Levels in Patients with Early-Stage Non-Small Cell Lung Cancer

Polydatin, a potential NOX5 agonist, synergistically enhances antitumor activity of cisplatin by stimulating oxidative stress in non‑small cell lung cancer

Impact of minimal solid and micropapillary components on invasive lung adenocarcinoma recurrence

Tim-3 Expression by Peripheral Natural Killer Cells and Natural Killer T Cells Increases in Patients with Lung Cancer - Reduction after Surgical Resection

Enhancement pattern of thyroid carcinoma with contrast-enhanced ultrasound

Robust Binary Neural Network Operation From 233 K to 398 K via Gate Stack and Bias Optimization of Ferroelectric FinFET Synapses

Rational application of EGFR-TKI adjuvant therapy in patients with completely resected stage IB-IIIA EGFR-mutant NSCLC: a systematic review and meta-analysis of 11 randomized controlled trials

Neoadjuvant EGFR-TKI Therapy for EGFR-Mutant NSCLC: A Systematic Review and Pooled Analysis of Five Prospective Clinical Trials

Facile Approach for Designing Icephobic Coatings Using Polymers/Silica Nanoparticle Composites via Self‐Formation of Superhydrophobic Surfaces

Area-Selective Deposition of Ruthenium Using Homometallic Precursor Inhibitor

Clinical option of pemetrexed-based versus paclitaxel-based first-line chemotherapeutic regimens in combination with bevacizumab for advanced non-squamous non-small-cell lung cancer and optimal maintenance therapy: evidence from a meta-analysis of randomized control trials

Suchergebnisse filtern